A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence

被引:125
作者
Temple, Jonathan L. [1 ]
Cordero, Paul [2 ]
Li, Jiawei [2 ]
Vi Nguyen [2 ]
Oben, Jude A. [2 ,3 ]
机构
[1] Kings Coll London, Fac Life Sci & Med, London WC2R 2LS, England
[2] UCL, Inst Liver & Digest Hlth, Rowland Hill St, London NW3 2PF, England
[3] NHS Fdn Trust, Guys & St Thomas Hosp, Dept Gastroenterol & Hepatol, Westminster Bridge Rd, London SE1 7EH, England
关键词
NAFLD; steatosis; obesity; children; adolescent; PLACEBO-CONTROLLED TRIAL; OBESE CHILDREN; METABOLIC SYNDROME; HEPATIC STEATOSIS; VITAMIN-E; URSODEOXYCHOLIC ACID; INSULIN-RESISTANCE; LIFE-STYLE; AMINOTRANSFERASE LEVELS; PEDIATRIC-PATIENTS;
D O I
10.3390/ijms17060947
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-Alcoholic Fatty Liver Disease (NAFLD) is now the most prevalent form of chronic liver disease, affecting 10%-20% of the general paediatric population. Within the next 10 years it is expected to become the leading cause of liver pathology, liver failure and indication for liver transplantation in childhood and adolescence in the Western world. While our understanding of the pathophysiological mechanisms underlying this disease remains limited, it is thought to be the hepatic manifestation of more widespread metabolic dysfunction and is strongly associated with a number of metabolic risk factors, including insulin resistance, dyslipidaemia, cardiovascular disease and, most significantly, obesity. Despite this, "paediatric" NAFLD remains under-studied, under-recognised and, potentially, undermanaged. This article will explore and evaluate our current understanding of NAFLD in childhood and adolescence and how it differs from adult NAFLD, in terms of its epidemiology, pathophysiology, natural history, diagnosis and clinical management. Given the current absence of definitive radiological and histopathological diagnostic tests, maintenance of a high clinical suspicion by all members of the multidisciplinary team in primary and specialist care settings remains the most potent of diagnostic tools, enabling early diagnosis and appropriate therapeutic intervention.
引用
收藏
页数:36
相关论文
共 190 条
[41]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873
[42]   The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence [J].
El-Serag, HB ;
Hampel, H ;
Javadi, F .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (03) :369-380
[43]   A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease [J].
Eng, Katharine ;
Lopez, Rocio ;
Liccardo, Daniela ;
Nobili, Valerio ;
Alkhouri, Naim .
DIGESTIVE AND LIVER DISEASE, 2014, 46 (11) :1008-1013
[44]   Serum Cytokeratin-18 Fragment Levels Are Useful Biomarkers for Nonalcoholic Steatohepatitis in Children [J].
Feldstein, Ariel E. ;
Alkhouri, Naim ;
De Vito, Rita ;
Alisi, Anna ;
Lopez, Rocio ;
Nobili, Valerio .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09) :1526-1531
[45]   The Role of Innate Cells Is Coupled to a Th1-Polarized Immune Response in Pediatric Nonalcoholic Steatohepatitis [J].
Ferreyra Solari, Nazarena E. ;
Eugenia Inzaugarat, Maria ;
Baz, Placida ;
De Matteo, Elena ;
Lezama, Carol ;
Galoppo, Marcela ;
Galoppo, Cristina ;
Chernavsky, Alejandra C. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (03) :611-621
[46]   Early left ventricular abnormality/dysfunction in obese children affected by NAFLD [J].
Fintini, D. ;
Chinali, M. ;
Cafiero, G. ;
Esposito, C. ;
Giordano, U. ;
Turchetta, A. ;
Pescosolido, S. ;
Pongiglione, G. ;
Nobili, V. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (01) :72-74
[47]   Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism [J].
Flachs, Pavel ;
Rossmeisl, Martin ;
Bryhn, Morten ;
Kopecky, Jan .
CLINICAL SCIENCE, 2009, 116 (1-2) :1-16
[48]   Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes [J].
Fracanzani, Anna Ludovica ;
Valenti, Luca ;
Bugianesi, Elisabetta ;
Andreoletti, Marco ;
Colli, Agostino ;
Vanni, Ester ;
Bertelli, Cristina ;
Fatta, Erika ;
Bignamini, Daniela ;
Marchesini, Giulio ;
Fargion, Silvia .
HEPATOLOGY, 2008, 48 (03) :792-798
[49]   Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target [J].
Fuchs, Michael .
JOURNAL OF LIPIDS, 2012, 2012
[50]   Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis [J].
George, P. S. ;
Pearson, E. R. ;
Witham, M. D. .
DIABETIC MEDICINE, 2012, 29 (08) :E142-E150